LARRY C KILGORE MD
Prescription History 1265482921
Obstetrics & Gynecology - Gynecologic Oncology in Knoxville, TN

Active since May 11, 2006PECOS EnrolledAccepts Medicare Assignment
95.69/100
CMS Quality Rating
1926 ALCOA HWY STE 370, KNOXVILLE, TN 37920(865) 305-5622 Get Directions

NPPES record last updated: May 2, 2024. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for LARRY C KILGORE MD, an active Gynecologic Oncology specialist practicing in Knoxville, TN. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 25 documented patient claims. Among these therapy options, the most frequently utilized medication is Medroxyprogesterone Acetate, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
25
Total Claims
47
30-Day Fills
Medroxyprogesterone Acetate
Most Prescribed · 14 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by LARRY C KILGORE MD in 2024, with prescription volumes, average cost per fill, and TN state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other TN PrescribersVs. TN Avg
Medroxyprogesterone Acetate14$22.27▼ Less than typical

About Medroxyprogesterone Acetate: Medroxyprogesterone is a type of hormone (progestin). Show more ▾

This medication is similar to the progesterone that your body naturally makes and is given to replace the hormone when your body is not making enough of it. This medication has several uses. In women who are not pregnant and not going through menopause, this medication is used to treat abnormal bleeding from the uterus and to restore normal menstrual periods in women who have stopped having them for several months (amenorrhea). Medroxyprogesterone is also used as part of combination hormone replacement therapy with estrogens to reduce menopause symptoms (such as hot flashes). Medroxyprogesterone is added to estrogen replacement therapy to reduce the risk of cancer of the uterus. Some brands of this medication may also be used to treat certain types of cancers (breast cancer, endometrial cancer). This medication must not be used to test for pregnancy. A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.

In 2024, this provider wrote 14 Medicare prescriptions for Medroxyprogesterone Acetate, about half the volume of the typical Tennessee prescriber of this medication (26.8). Medicare paid an average of $22.27 per fill, versus $15.68 statewide.

How often this provider prescribes it

This provider
14
TN average
26.8

This provider prescribes this medication less often than the average TN prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$22.27
TN average
$15.68

Gross Part D cost per fill; not the patient's out-of-pocket price.

36
30-Day Fills
standardized to 30-day supplies
1,045
Days of Medication
total across all patients in 2024
Ondansetron Hcl11$6.44▼ below TN avg▼ Less than typical

About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾

It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

In 2024, this provider wrote 11 Medicare prescriptions for Ondansetron Hcl, about a third of the volume of the typical Tennessee prescriber of this medication (33.8). Medicare paid an average of $6.44 per fill, versus $14.26 statewide.

How often this provider prescribes it

This provider
11
TN average
33.8

This provider prescribes this medication less often than the average TN prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.44
TN average
$14.26

This provider's average cost per fill is below the TN average for this medication.

11
30-Day Fills
standardized to 30-day supplies
118
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average TN prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the TN average cost per fill.

About this data. The prescription history for LARRY C KILGORE MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Gynecologic Oncology prescribing approach at this Knoxville, TN practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among TN prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.